BMRN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The zones of discrimination for M-Score is as such:
An M-Score of less than -2.22 suggests that the company is not an accounting manipulator.
An M-Score of greater than -2.22 signals that the company is likely an accounting manipulator.
During the past 13 years, the highest Beneish M-Score of Biomarin Pharmaceutical Inc was 3.79. The lowest was -4.43. And the median was -2.32.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Z-Score) or business trend (F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Biomarin Pharmaceutical Inc for today is based on a combination of the following eight different indices:
|M||=||-4.84||+||0.92 * DSRI||+||0.528 * GMI||+||0.404 * AQI||+||0.892 * SGI||+||0.115 * DEPI|
|=||-4.84||+||0.92 * 0.9615||+||0.528 * 1.0092||+||0.404 * 2.318||+||0.892 * 1.1876||+||0.115 * 1.2829|
|-||0.172 * SGAI||+||4.679 * TATA||-||0.327 * LVGI|
|-||0.172 * 1.1197||+||4.679 * 0.0219||-||0.327 * 0.8368|
|This Year (Dec15) TTM:||Last Year (Dec14) TTM:|
|Accounts Receivable was $165.0 Mil.|
Revenue was 227.936 + 208.904 + 250.523 + 203.264 = $890.6 Mil.
Gross Profit was 185.338 + 172.185 + 210.645 + 170.451 = $738.6 Mil.
Total Current Assets was $1,089.6 Mil.
Total Assets was $3,729.4 Mil.
Property, Plant and Equipment(Net PPE) was $704.2 Mil.
Depreciation, Depletion and Amortization(DDA) was $47.2 Mil.
Selling, General & Admin. Expense(SGA) was $402.3 Mil.
Total Current Liabilities was $445.5 Mil.
Long-Term Debt was $662.3 Mil.
Net Income was 68.617 + -90.926 + -81.989 + -67.501 = $-171.8 Mil.
Non Operating Income was -7.722 + -7.631 + -9.325 + -7.026 = $-31.7 Mil.
Cash Flow from Operations was -68.037 + -2.85 + -12.991 + -137.811 = $-221.7 Mil.
|Accounts Receivable was $144.5 Mil.
Revenue was 230.068 + 176.549 + 191.787 + 151.552 = $750.0 Mil.
Gross Profit was 191.747 + 146.629 + 160.577 + 128.736 = $627.7 Mil.
Total Current Assets was $1,397.6 Mil.
Total Assets was $2,475.4 Mil.
Property, Plant and Equipment(Net PPE) was $523.5 Mil.
Depreciation, Depletion and Amortization(DDA) was $45.9 Mil.
Selling, General & Admin. Expense(SGA) was $302.5 Mil.
Total Current Liabilities was $235.7 Mil.
Long-Term Debt was $642.9 Mil.
1. DSRI = Days Sales in Receivables Index
A large increase in DSR could be indicative of revenue inflation.
|DSRI||=||(Receivables_t / Revenue_t)||/||(Receivables_t-1 / Revenue_t-1)|
|=||(164.959 / 890.627)||/||(144.472 / 749.956)|
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
|=||(GrossProfit_t-1 / Revenue_t-1)||/||(GrossProfit_t / Revenue_t)|
|=||(172.185 / 749.956)||/||(185.338 / 890.627)|
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
|AQI||=||(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)||/||(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)|
|=||(1 - (1089.639 + 704.207) / 3729.368)||/||(1 - (1397.64 + 523.516) / 2475.379)|
4. SGI = Sales Growth Index
Ratio of sales in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
5. DEPI = Depreciation Index
Measured as the ratio of the rate of depreciation in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
|DEPI||=||(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))||/||(Depreciation_t / (Depreciaton_t + PPE_t))|
|=||(45.871 / (45.871 + 523.516))||/||(47.187 / (47.187 + 704.207))|
6. SGAI = Sales, General and Administrative expenses Index
The ratio of SGA expenses in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
|SGAI||=||(SGA_t / Sales_t)||/||(SGA_t-1 /Sales_t-1)|
|=||(402.271 / 890.627)||/||(302.53 / 749.956)|
7. LVGI = Leverage Index
The ratio of total debt to total assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase$sgai= in leverage
|LVGI||=||((LTD_t + CurrentLiabilities_t) / TotalAssets_t)||/||((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)|
|=||((662.286 + 445.457) / 3729.368)||/||((642.902 + 235.739) / 2475.379)|
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
|=||(NetIncome_t - NonOperatingIncome_t||-||CashFlowsfromOperations_t)||/||TotalAssets_t|
|=||(-171.799 - -31.704||-||-221.689)||/||3729.368|
An M-Score of less than -2.22 suggests that the company will not be a manipulator. An M-Score of greater than -2.22 signals that the company is likely to be a manipulator.
Biomarin Pharmaceutical Inc has a M-score of -1.64 signals that the company is likely to be a manipulator.
Altman Z-Score, Piotroski F-Score, Accounts Receivable, Revenue, Gross Profit, Total Current Assets, Total Assets, Property, Plant and Equipment, Depreciation, Depletion and Amortization, Selling, General & Admin. Expense, Total Current Liabilities, Long-Term Debt, Net Income, Non Operating Income, Cash Flow from Operations
Biomarin Pharmaceutical Inc Annual Data
Biomarin Pharmaceutical Inc Quarterly Data